About Brian Stuglik

Global leader in the oncology pharmaceutical sector having successfully developed, acquired and launched several multi-billion dollar oncology brands across multiple tumor types and therapeutic approaches. Over 3 decades of experience in US and International pharmaceutical development, product strategy, commercialization and business development; and, has cultivated an extensive network with specialists and companies developing new treatment approaches for patients living with cancer.
Recently, founded Proventus Health Solutions, a company specializing in helping oncology biotech companies create greater value by integrating development and commercial considerations into a unified approach. A member of the board of directors for Verastem Oncology (VSTM) and Oncopeptides AB (ONCO).